Basic Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2006; 12(15): 2375-2381
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2375
Table 1 PCR primers used for iNOS, eNOS, TNF-α and GAPDH
NameSenseAntisenseProduct length (bp)
iNOSTTCTTTGCTTCTGTGCTAATGCGGTTGTTGCTGAACTTCCAATCGT1061
eNOSTGGGCAGCATCACCTACGATAGGAACCACTCCTTTTGATCGAGTTAT202
TNF-αGCCAATGGCATGGATCTCAAAGCAGAGCAATGACTCCAAAGT357
GAPDHTCCCTCAAGATTGTCAGCAAAGATCCACAACGGATACATT309
Table 2 Pathological scores, serum ALT levels and liver MDA contents in different experimental groups (mean±SD)
GroupsFatty liverNecroinflammationALT(U/L-1)MDA(nmol/mg-1 protein)
4-wk dextrose0.2 ± 0.251.0 ± 1.043.4 ± 3.054.83 ± 0.70
4-wk ethanol2.1 ± 0.64a16.1 ± 2.17 a117.3 ± 6.92 a8.64 ± 0.62 a
6-wk dextrose0.6 ± 0.351.6 ± 1.5246.0 ± 3.165.36 ± 0.31
6-wk ethanol2.9 ± 0.64b19.9 ± 4.29 b124.1 ± 7.28 b9.38 ± 0.39 b
Table 3 Liver NO contents, iNOS and eNOS activity in different experimental groups (mean±SD)
GroupsNO (µmol/g-1 protein)iNOS (U/mg-1 protein)eNOS(U/mg-1 protein)
4-wk dextrose0.75 ± 0.140.27 ± 0.070.64 ± 0.06
4-wk ethanol1.67 ± 0.150.60 ± 0.07 a0.48 ± 0.03 a
6-wk dextrose0.87 ± 0.070.35 ± 0.060.58 ± 0.04
6-wk ethanol1.84 ± 0.12 b0.70 ± 0.09 b0.43 ± 0.05 b